跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35,347 条关于
“ACT Capital Management”
全部
35,347
临床试验
21,472
药物
710
机构
396
资讯
12,769
6个月前
ACT Capital Management Invests $8 Million in TG Therapeutics Despite 30% Stock Decline
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
6个月前
Superstring Capital Management Invests $6.84 Million in CNS Drug Developer Axsome Therapeutics
9个月前
Tang Capital Management Invests $56.8 Million in Celcuity Following Positive Phase 3 Gedatolisib Results
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
去年
Bipartisan EPIC Act Seeks to Eliminate IRA's Small Molecule Drug Development Disincentive
去年
FDA Initiates PDUFA VIII Reauthorization Process with Public Meeting and Assessment Report
7天前
Dietary Supplement Innovation Act Targets FDA's Drug Preclusion Clause
去年
LUMRYZ Maintains Market Exclusivity as Court Upholds FDA Approval in Narcolepsy Treatment
去年
WuXi Companies Consider Asset Sales Amid US BIOSECURE Act Pressure
第 1 页,共 1277 页
上一页
下一页